Showing results (311-320 of 825) with videos related to

Sort By:
Pageof 83
Diabetes|June 5, 2010
Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up studyJohanna W M Nin, Anders Jorsal, Isabel Ferreira, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 18, 2010
Body composition as determinant of thrombin generation in plasma: the Hoorn studyHanneke J B H Beijers, Isabel Ferreira, Henri M H Spronk, et al.
The Journal of Clinical Endocrinology and Metabolism|May 27, 2010
Angiotensin II enhances insulin-stimulated whole-body glucose disposal but impairs insulin-induced capillary recruitment in healthy volunteersAmy M Jonk, Alfons J H M Houben, Nicolaas C Schaper, et al.
Diabetologia|July 4, 2012
Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up studyJ W M Nin, I Ferreira, C G Schalkwijk, et al.
Pediatric Obesity|January 31, 2013
Maternal smoking during pregnancy and childhood overweight and fat distribution: the KOALA Birth Cohort StudyS H Timmermans, M Mommers, J S Gubbels, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 27, 2020
Effects of diet-induced weight loss on postprandial vascular function after consumption of a mixed meal: Results of a randomized controlled trial with abdominally obese menPeter J Joris, Jogchum Plat, Yvo H A M Kusters, et al.
Diabetes, Obesity & Metabolism|July 2, 2024
Incretin-based therapy and the risk of diabetic foot ulcers and related eventsNikki C C Werkman, Johanna H M Driessen, Olaf H Klungel, et al.
Diabetes|June 8, 2017
Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease in Individuals With Type 1 Diabetes: A 12-Year Follow-up StudyNordin M J Hanssen, Jean L J M Scheijen, Anders Jorsal, et al.
Diabetologia|May 19, 2010
Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trialF Persson, P Rossing, H Reinhard, et al.
European Journal of Clinical Investigation|March 19, 2003
Homocysteine-lowering treatment with folic acid plus vitamin B6 lowers urinary albumin excretion but not plasma markers of endothelial function or C-reactive protein: further analysis of secondary end-points of a randomized clinical trialE G J Vermeulen, J A Rauwerda, M van den Berg, et al.
Pageof 83